Kishimoto, Atsuhiro
Komiyama, Maki
Wada, Hiromichi
Satoh-Asahara, Noriko
Yamakage, Hajime
Ajiro, Yoichi
Aoyama, Hiroki
Katsuura, Yasuhiro
Imaizumi, Atsushi
Hashimoto, Tadashi
Sunagawa, Yoichi
Morimoto, Tatsuya
Kanai, Masashi
Kakeya, Hideaki
Hasegawa, Koji
Article History
Received: 25 April 2024
Accepted: 9 June 2024
First Online: 24 June 2024
Declarations
:
: The trial was approved by the Nara Medical University Ethics Committee and registered with the Japan Registry of Clinical Trials (CRB5200002).
: Not applicable as no personal data were used in this article.
: This study was funded by a joint research agreement between NHO Kyoto Medical Center and Therabiopharma Inc. M. Kanai and H. Kakeya own equity and they are the scientific consultants of Therabiopharma Inc.